Evaluation of the Synergism Mechanism of Tamoxifen and Docetaxel by Nanoparticles

Author:

Zhu Zhihong1ORCID,Pan Hao2,Li Yuenan2,Pan Weisan2

Affiliation:

1. College of Pharmaceutical Science, Zhejiang Chinese Medical University, Hangzhou, 310053, China

2. College of Pharmacy, Liaoning University, Shenyang 110036, China

Abstract

Background: Our previous studies have shown that Docetaxel (DTX) and Tamoxifen (TMX) loaded nanoparticles(Co-NPs) could exhibit a synergistic effect on estrogen receptor positive cell lines. In the current study,we have studied the synergistic effect of Co-NPs and underlying possible molecular mechanism. Methods: Cell apoptosis assay, pharmacokinetic experiment and immunohistochemistry experiment were used to explore the synergistic effect and underlying possible mechanism in vitro and in vivo. Results: Cell apoptosis assay revealed that Co-NPs could mediate cell sensitization to a cytotoxic agent, resulting in remarkable cell apoptosis. In addition, pharmacokinetic experiment research showed that Co-NPs have longer circulation time in vivo, which could prolong the treatment time of the chemotherapeutic drugs. Immunohistochemistry experiment revealed that the Co-NPs could downregulate the expression of P-gp level to reduce the drugs’ efflux. Conclusion: The possible mechanism of the synergistic effect of DTX and TMX by Co-NPs was attributed to the longer in vivo circulation time, significantly increased rate of cell apoptosis and downregulated expression of P-gp level to the tumor cells.

Funder

Zhejiang Chinese Medical University

Publisher

Bentham Science Publishers Ltd.

Subject

Cancer Research,Pharmacology,Molecular Medicine

Reference18 articles.

1. Peter M.; Ellis E.T.V.; Yee C.; Ung, Immune checkpoint inhibitors for patients with advanced nonesmall-cell lung cancer: A systematic review. Clin Lung Cancer 2017,18(5),444-459

2. Visconti R.; Grieco D.; Fighting tubulin-targeting anticancer drug toxicity and resistance. Endocr Relat Cancer 2017,24(9),T107-T117

3. Azzoli C.G.; Baker S.; Temin S.; Pao W.; Aliff T.; Brahmer J.; Johnson D.H.; Laskin J.L.; Masters G.; Milton D.; Nordquist L.; Pfister D.G.; Piantadosi S.; Schiller J.H.; Smith R.; Smith T.J.; Strawn J.R.; Trent D.; Giaccone G.; American Society of Clinical Oncology. American Society of Clinical Oncology Clinical Practice Guideline update on chemotherapy for stage IV non-small-cell lung cancer. J Clin Oncol 2009,27(36),6251-6266

4. Choudhury B.G.; Pandeya M.; Kumbharc S.A.; Tekaded R.K.; Iyere A.K.; Kesharwani P.; Recent advances in TPGS-based nanoparticles of docetaxel for improved chemotherapy. Int J Pharm 2017,2017(529),506-522

5. (a) Jain, A.K.; Sanyog Jain, K.T. Co-encapsulation of tamoxifen and quercetin in polymeric nanoparticles: Implications on oral bioavailability, antitumor efficacy and drug induced toxicit. Mol. Pharm., 2013, 2013(10), 3459-3474. (b Shien, T.; Iwata, H.; Aogi, K.; Fukutomi, T.; Inoue, K.; Kinoshita, T.; Takahashi, M.; Matsui, A.; Shibata, T.; Fukuda, H. Tamoxifen versus tamoxifen plus doxorubicin and cyclophosphamide as adjuvant therapy for node-positive postmenopausal breast cancer: Results of a Japan Clinical Oncology Group Study (JCOG9401). Int J Clin Oncol 2014,19(6),982-988

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

全球学者库

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"全球学者库"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前全球学者库共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2023 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3